ANNX
USDAnnexon Inc. Common Stock
$2.520-0.140 (-5.263%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$2.660
最高
$2.670
最低
$2.510
交易量
1.85M
公司基本面
市值
276.5M
行業
生物科技
國家
United States
交易統計
平均交易量
1.80M
交易所
NMS
貨幣
USD
52週範圍
最低 $1.285當前 $2.520最高 $7.85
相關新聞
GlobeNewswire
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient
查看更多
GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical
查看更多
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14
HC Wainwright & Co. analyst Andrew Fein maintains Annexon with a Buy and lowers the price target from $20 to $14.
查看更多
